| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:526143444:1810 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:526143444:1810?format=raw |
LEADER: 01810cam a2200457 i 4500
001 3967405
005 20221027011452.0
008 920821s1974 gw a b 100 0 ger
010 $a 77467836
015 $aGFR76-A
020 $a3871930148 :$cDM18.00
035 $a(OCoLC)38239551
035 $a(OCoLC)ocm38239551
035 $a(CStRLIN)NYCM92-B4116
035 $9AGE6935HS
035 $a(NNC)3967405
035 $a3967405
040 $dNNC-M
041 0 $agereng
050 00 $aRC685.C6$bI584 1973
082 0 $a615/.71
111 2 $aInternationales Lidoflazin-Symposium$d(1973 :$cDüsseldorf, Germany)
245 10 $aLidoflazin :$bInternationales Lidoflazin-Symposium am 9. März 1973 in Düsseldorf /$chrsg. von H. Hochrein.
260 $aAulendorf :$bEditio Cantor,$c1974.
300 $a120 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aArzneimittel Forschung. Beiheft ;$v26
500 $aPapers in German and English.
504 $aIncludes bibliographical references.
650 0 $aCoronary heart disease$xChemotherapy$vCongresses.
650 0 $aLidoflazine$xTherapeutic use$vCongresses.
650 0 $aLidoflazine$xTesting$vCongresses.
650 2 $aHeart Diseases$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D006331Q000188
650 2 $aVasodilator Agents$xpharmacology.$0https://id.nlm.nih.gov/mesh/D014665Q000494
650 2 $aVasodilator Agents$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D014665Q000627
650 2 $aLidoflazine.$0https://id.nlm.nih.gov/mesh/D008013
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aHochrein, Hans.$0http://id.loc.gov/authorities/names/n88641832
830 0 $aArzneimittel Forschung.$pBeiheft ;$v26.
852 80 $boff,hsr$hSerial$iA